Carboplatin/paclitaxel/pembrolizumab

Myelosuppression, thrombocytopenia and acquired pembrolizumab resistance: case report

    This is a preview of subscription content, log in to check access.

    Reference

    1. Lyu M, et al. The combined use of chemotherapy and radiotherapy with PD-1 inhibitor, pembrolizumab, in advanced cervical cancer: A case report. OncoTargets and Therapy 13: 4465-4471, 21 May 2020. Available from: URL: http://doi.org/10.2147/OTT.S245190

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Carboplatin/paclitaxel/pembrolizumab. Reactions Weekly 1810, 65 (2020). https://doi.org/10.1007/s40278-020-80085-0

    Download citation